Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Aldevron
Aldevron
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part II
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials
Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer
Denis will be responsible for optimising global operations for the company
SeaBeLife awarded over €1.5 million in i-Nov innovation competition
Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Aldevron launches CRISPR RNP manufacturing service
The platform is designed to deliver a clinical grade RNP complex generated from a CRISPR nuclease and guide RNA (gRNA)
Manufacturing
PE firm acquires Aldevron
The CDMO from North Dakota has additional operations in Madison, Wisconsin, and Freiburg, Germany
Design & Build
Aldevron to build gene therapy campus at US headquarters
The nearly 0.5 million sqft facility in Fargo could employ 1,000 people when fully operational in 2021
Design & Build
Aldevron announces German antibody facility expansion
Expansion plans by the US-based CMO include 4,300 sqft of laboratory and production space
Subscribe now